Grant: Master's Award: Canada Graduate Scholarships
McGill University
$27,000.00
Exploring the role of CD109 in the etiology and progression of Idiopathic Pulmonary Fibrosis
EF 2024-25
Résumé
Idiopathic pulmonary fibrosis (IPF) is a serious and progressive lung disease that causes scarring in the lungs, making it increasingly hard to breathe and ultimately leading to respiratory failure. Affecting millions globally, IPF has limited treatment options, with lung transplantation as the only effective intervention. This lack of treatment underscores an urgent need for new insights into the disease. Although we know that certain cell types, like fibroblasts and immune cells called macrophages, contribute to lung scarring, how they interact at the molecular level remains a mystery.Our research focuses on a protein called CD109, which we believe could play a critical role in reducing lung fibrosis in IPF. Our preliminary studies suggest that CD109 might help curb fibrosis by influencing fibroblasts and macrophages, altering their behavior to reduce scarring. Through a combination of cell-based and animal studies, we aim to investigate how CD109 affects the crosstalk between these cells.To accomplish this, we will study lung cells from both IPF patients and healthy controls, reducing CD109 levels and analyzing the impact on fibrosis-related signals. We will also use a mouse model of lung fibrosis to explore CD109 effects on lung structure and function. Additionally, advanced 3D bioprinting techniques will allow us to closely examine interactions between fibroblasts and macrophages, providing a comprehensive view of how CD109 influences fibrosis progression.By uncovering the mechanisms that drive lung fibrosis progression, this research has the potential to unlock new treatment strategies that could benefit patients suffering from this currently incurable condition and elevate their quality-of-life.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database
Tel que publié
Id
529797
Name
Garousi Setareh
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Exploring the role of CD109 in the etiology and progression of Idiopathic Pulmonary Fibrosis
Programtype2
Studentship Programs
Orgnameinp2
McGill University
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
3d Bioprinting; Cd109; Cd109 Ko Mouse Model; Extracellular Matrix Proteins; Idiopathic Pulmonary Fibrosis; Lung Fibrosis; M1/M2 Macrophage; Macrophage Polarization; Patient Cells; Tgf Beta Signaling
Abstract
Idiopathic pulmonary fibrosis (IPF) is a serious and progressive lung disease that causes scarring in the lungs, making it increasingly hard to breathe and ultimately leading to respiratory failure. Affecting millions globally, IPF has limited treatment options, with lung transplantation as the only effective intervention. This lack of treatment underscores an urgent need for new insights into the disease. Although we know that certain cell types, like fibroblasts and immune cells called macrophages, contribute to lung scarring, how they interact at the molecular level remains a mystery.Our research focuses on a protein called CD109, which we believe could play a critical role in reducing lung fibrosis in IPF. Our preliminary studies suggest that CD109 might help curb fibrosis by influencing fibroblasts and macrophages, altering their behavior to reduce scarring. Through a combination of cell-based and animal studies, we aim to investigate how CD109 affects the crosstalk between these cells.To accomplish this, we will study lung cells from both IPF patients and healthy controls, reducing CD109 levels and analyzing the impact on fibrosis-related signals. We will also use a mouse model of lung fibrosis to explore CD109 effects on lung structure and function. Additionally, advanced 3D bioprinting techniques will allow us to closely examine interactions between fibroblasts and macrophages, providing a comprehensive view of how CD109 influences fibrosis progression.By uncovering the mechanisms that drive lung fibrosis progression, this research has the potential to unlock new treatment strategies that could benefit patients suffering from this currently incurable condition and elevate their quality-of-life.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Garousi, Setareh
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~